The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Recreational ketamine use has increased in the United States in recent years, outpacing its rise as a treatment for depression, a new analysis suggests. The hallucinogenic drug — a controlled ...

Ketamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and elsewhere. However, bear in mind that the science isn’t fully settled and, ...

The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...

A bunch of evidence has shown that ketamine could be used in therapy for depression, although how it achieves this remains somewhat unclear. In a new study, tiny zebrafish suffering from a sense ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Elon Musk said in a March 2024 interview that he takes ketamine to treat depression. He claimed to have a doctor's prescription for the drug. How often, or under what circumstances, he uses ...